Other Programs

5HT2c Agonist Program

In addition to our regenerative medicine programs, we are focused on creating a new class of compounds that target a key receptor in the brain – the 5HT2c receptor. Potent and selective compounds that act at this receptor have shown potential for treating obesity and other conditions, such as schizophrenia. We have developed a novel and proprietary portfolio of compounds that exhibit best in class characteristics, that we believe have the potential to be developed as safer and more effective medicines for these and potentially other conditions where this pathway is clinically relevant.


Learn More